Reversing the Chirality of Surface Ligands Can Improve the Biosafety and Pharmacokinetics of Cationic Gold Nanoclusters

Charge-Reversible Nanoparticles: Advanced Delivery Systems for Therapy and Diagnosis

The past two decades have witnessed a rapid progress in the development of surface charge-reversible nanoparticles (NPs) for drug delivery and diagnosis. These NPs are able to elegantly address the polycation dilemma. Converting their surface charge from negative/neutral to positive at the target site, they can substantially improve delivery of drugs and diagnostic agents. By specific stimuli like a shift in pH and redox potential, enzymes, or exogenous stimuli such as light or heat, charge reversal of NP surface can be achieved at the target site. The activated positive surface charge enhances the adhesion of NPs to target cells and facilitates cellular uptake, endosomal escape, and mitochondrial targeting. Because of these properties, the efficacy of incorporated drugs as well as the sensitivity of diagnostic agents can be essentially enhanced. Furthermore, charge-reversible NPs are shown to overcome the biofilm formed by pathogenic bacteria and to shuttle antibiotics directly to the cell membrane of these microorganisms. In this review, the up-to-date design of charge-reversible NPs and their emerging applications in drug delivery and diagnosis are highlighted.

Fluorescence or Phosphorescence? The Metallic Composition of the Nanocluster Kernel Does Matter

It remains challenging to manipulate the nature of photoluminescence as either fluorescence or phosphorescence for a correlated cluster series. In this work, two correlated nanoclusters, Au₅ Ag₁₁ (SR)₈ (DPPOE)₂ and Pt₁ Ag₁₆ (SR)₈ (DPPOE)₂ with comparable structure features, were synthesized and structurally determined. These two alloy nanoclusters displayed distinct photoluminescent nature-the Au₅ Ag₁₁ nanocluster is fluorescent, whereas the Pt₁ Ag₁₆ nanocluster is phosphorescent. The decay processes of the excited electrons in these two nanoclusters have been explicitly mapped out by both experimental and theoretical approaches, disclosing the mechanisms of their fluorescence and phosphorescence. Specifically, the metallic compositions of the nanocluster kernels mattered in determining their photoluminescent nature. The results herein provide an intriguing nanomodel that enables us to grasp the origin of photoluminescence at the atomic level, which further paves the way for fabricating novel nanoclusters or cluster-based nanomaterials with customized photophysical properties.

The influence of modified molecular (D/L-serine) chirality on the theragnostics of PAMAM-based nanomedicine for acute kidney injury

Acute kidney injury (AKI) is a severe clinical disease with extremely high morbidity and mortality. It is challenging to find a simple method for early detection of AKI and monitoring the treatment results. Renal tubular damage and inflammation are early events in AKI. Renal tubular damage is conducive to the accumulation of small-sized nanoparticles in the kidney, and inflammation is related to the excessive production of H₂O₂. Recent studies proved that chiral molecule modification of nanomaterials is a powerful strategy to regulate their biodistribution. Thus, L-serine and D-serine modified poly(amidoamine) (PAMAM) dendrimers were synthesized and used as fluorescent probe (NPSH) carriers to obtain L-SPH and D-SPH, respectively. D-SPH has a strong accumulation capability in the kidney of AKI mice. Then, the H₂O₂ fluorescent probe can detect the excessively produced H₂O₂ to generate fluorescence to diagnose AKI. Subsequently, the anti-inflammatory drug manganese pentacarbonyl bromide (CORM) was loaded in D-SPH to obtain D-SPHC with AKI theragnostic functions. Simultaneously, the D-SPHC fluorescence signal intensity change during the treatment can be used to monitor the recovery process. This study is the first report of chiral materials used in the diagnosis and treatment of AKI.